Cybin Inc (CLXPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLXPF | NBP | DMAC | ||
| Company | Cybin Inc | Novabridge Biosciences ADR | Diamedica Therapeutics Inc | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 3.0500 | 4.02 | 8.62 | ||
| High | 3.2000 | 4.36 | 8.95 | ||
| Low | 2.8736 | 4.02 | 8.42 | ||
| Latest | 3.0200 | 4.21 | 8.76 | ||
| Change | -0.0400 | +0.14 | +0.09 | ||
| % Change | -1.31% | +3.44% | +1.04% | ||
| Volume | 864,300 | 629,600 | 354,900 | ||
| 20-Day Average Volume | 1,094,590 | 464,570 | 552,460 | ||
| Previous Close | 3.0600 | 4.07 | 8.67 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.8482 | 4.05 | 8.46 | ||
| 20-Day Raw Stochastic | 71.64% | 54.95% | 60.67% | ||
| 20-Day Relative Strength | 62.45 | 50.61 | 58.88 | ||
| Weighted Alpha | +130.72 | +95.18 | +48.25 | ||
| Today's Opinion | N/A | 40% Buy | 100% Buy | ||
| Previous Opinion | N/A | 24% Buy | 100% Buy | ||
| Last Month's Opinion | N/A | 64% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +11.46% since 07/28/21 | +4.73% since 12/09/25 | -3.42% since 12/09/25 | ||
| Low | 2.7300 on 07/29/21 | 3.88 on 12/11/25 | 8.40 on 12/15/25 | ||
| High | 3.3800 on 08/02/21 | 4.36 on 12/16/25 | 10.42 on 12/10/25 | ||
| 1-Month | |||||
| %Chg | +42.45% since 07/02/21 | +1.45% since 11/14/25 | +47.72% since 11/14/25 | ||
| Low | 2.1105 on 07/08/21 | 3.60 on 12/03/25 | 5.80 on 11/17/25 | ||
| High | 3.3800 on 08/02/21 | 4.71 on 11/20/25 | 10.42 on 12/10/25 | ||
| 3-Month | |||||
| %Chg | +79.76% since 05/04/21 | +13.17% since 09/16/25 | +25.68% since 09/16/25 | ||
| Low | 1.3429 on 06/01/21 | 3.40 on 09/29/25 | 5.26 on 11/13/25 | ||
| High | 3.3800 on 08/02/21 | 6.79 on 10/16/25 | 10.42 on 12/10/25 | ||
| 6-Month | |||||
| %Chg | +76.61% since 02/04/21 | +67.06% since 06/16/25 | +149.57% since 06/16/25 | ||
| Low | 0.9500 on 03/30/21 | 1.65 on 07/29/25 | 3.47 on 07/02/25 | ||
| High | 3.3800 on 08/02/21 | 6.79 on 10/16/25 | 10.42 on 12/10/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 453,224 | 469,133 | 451,508 | ||
| Shares Outstanding, K | 148,598 | 115,266 | 52,077 | ||
| Annual Sales | 650,000 | 0 | 0 | ||
| Annual Net Income | -24,420,000 | -22,230,000 | -24,440,000 | ||
| Last Quarter Sales | N/A | 0 | 0 | ||
| Last Quarter Net Income | N/A | -5,500,000 | -8,620,000 | ||
| 60-Month Beta | N/A | 1.63 | 1.31 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.07 on 08/20/25 | -0.17 on 11/12/25 | ||
| Latest Earnings Date | 09/27/21 | 12/18/25 | 03/16/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||